ERCC1 and ovarian cancer: Furthermore, a correlation has been identified by researchers between chemo-resistance and a distinct set of genes (MRP1–10, MDR1, RRM1/2, ERCC1) that have potential as therapeutic targets for patients with chemo-resistant ovarian cancer [28].